BioDue Expands with Acquisition of Biokosmes and Rolf Kullgren
Deal News | May 12, 2025 | Riverside
The Riverside Company, a global private equity firm, has announced that its portfolio company BioDue S.p.A. has signed a definitive agreement to acquire Biokosmes and Rolf Kullgren from Venture Life Group plc (VLG). This acquisition marks the second add-on for BioDue following Riverside's investment earlier this year. BioDue is expanding its reach in the food supplements, medical devices, and cosmetics sectors, and this acquisition will incorporate VLG's CDMO business unit. This strategic move aims to enhance BioDue's position as a comprehensive service provider in these sectors. The acquisition is anticipated to offer significant synergies and is aligned with Riverside's focus on healthcare and consumer products. VLG will maintain a long-term manufacturing agreement with BioDue after the transaction, ensuring continuous collaboration.
Sectors
- Private Equity
- Healthcare
- Consumer Products
Geography
- Italy – BioDue, the acquiring company, is based in Italy, which is central to the transaction.
- United Kingdom – The seller, Venture Life Group, is a UK-headquartered company.
- Sweden – The acquisition includes manufacturing sites in Sweden as part of the expansion.
Industry
- Private Equity – The investment is led by The Riverside Company, a private equity firm, indicating this transaction belongs to the private equity sector.
- Healthcare – BioDue and VLG operate in the healthcare industry, specifically in medical devices and supplements.
- Consumer Products – Both companies are involved in the consumer healthcare products sector, producing items such as cosmetics and food supplements.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| The Riverside Company | Private Equity Firm | Company | A global investment firm focused on small and mid-market companies. |
| BioDue S.p.A. | Acquiring Company | Company | An Italian company that produces food supplements, medical devices and cosmetics. |
| Venture Life Group plc | Selling Company | Company | A UK-quoted consumer healthcare business providing medical devices and supplements. |
| Biokosmes and Rolf Kullgren | Target Company | Company | A business unit of Venture Life Group specializing in cosmetics and medical devices. |
| Karsten Langer | Managing Partner, Europe | Person | Manages European investments and operations for Riverside. |
| Rafael Alvarez-Novoa | Partner | Person | Co-led the deal for Riverside with Damien Gaudin. |
| VLG's CDMO Business Unit | Target Business Unit | Company | Part of VLG focusing on contract development and manufacturing. |
| Gianluca Braguti | CEO of VLG's CDMO Business Unit | Person | Leading the CDMO business unit of VLG in strategic alignment. |